- The trend backdrop is active with a 11-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
FCL
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Fineotex Chemical Limited · Basic Materials · Specialty Chemicals
Latest close
41.64 INR
5.7%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 40.6% above the Trend Line and sits at 88.6% of its 52-week range. The latest completed week returned 5.7%, after a 12.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal.
Setup score
57
out of 100
Latest Close
41.64 INR
7 Aug 2026
1W Return
5.7%
latest completed week
4W Return
12.6%
short-term follow-through
12W Return
63.7%
quarterly tape
Trend Breadth
26.9%
14 of 52 weeks active
Volume Ratio
0.6x
vs 13-week average
- Next-week expectancy is negative at 39.94% based on similar historical setup states.
- 2 reversal markers appear in the recent smart-money tape.
- Recent volatility is running well above the one-year baseline.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
5.7%
Latest completed week; four-week move 12.6%.
Indicator stack
53/56
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 39.94%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
53/100
26 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 40.6% above the Trend Line and sits at 88.6% of its 52-week range. The latest completed week returned 5.7%, after a 12.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.9312-week average 0.63
12-week confirmation
Trend active11/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.93Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 12.6% over four weeks, 63.7% over 12 weeks, and 77.6% over one year. The current trend has remained active for 11 consecutive weeks.
Performance by holding period
Active trend streak11 weeks
Active weeks in one year14
Trend breadth26.9%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.56Latest activity-pressure read.
Pressure change-49.6%Four-week change in activity pressure.
Leadership51.39Latest relative-leadership reading.
RS change21.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 88%
Model confidence 82%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength23/100Blend of value, momentum, and quality. Underlying universe rank 78; rank 1 is best.
Value17/100Relative valuation strength. Underlying universe rank 84; rank 1 is best.
Quality23/100Profitability and accounting quality. Underlying universe rank 78; rank 1 is best.
Momentum95/100Medium-term price momentum. Underlying universe rank 6; rank 1 is best.
Growth35/100Revenue and earnings growth. Underlying universe rank 66; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework33/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 44.6x Price divided by trailing earnings.
- Price / sales
- 6.3x Market value relative to trailing revenue.
- EV / EBITDA
- 29.1x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -1.0% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 33.0% Gross profit retained from each unit of revenue.
- Operating margin
- 15.7% Operating profit retained from revenue.
- Free-cash-flow margin
- -6.3% Free cash flow generated from revenue.
- Return on invested capital
- 10.7% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 44.8% Latest one-year revenue growth.
- EPS growth
- -90.1% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -2853.0% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 2/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.3% Cash dividends relative to market value.
- Buyback yield
- 1.0% Net share repurchases relative to market value.
- Shareholder yield
- 1.3% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -0.2x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment53/100
Weighted news tone is neutral across 26 relevant articles.
7 positive · 17 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-6.5%Distance below the 52-week high.
13-week volatility11.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2612 weeks finished lower.
Best week+30.7%Week of 22 May.
Worst week-9.6%Week of 15 May.
Latest week+5.7%Week of 7 Aug.
Shape of recent returns
Strong gains9
Modest gains5
Flat weeks0
Modest losses5
Sharp losses7
Recent vol11.0%13-week weekly-return volatility.
Base vol7.8%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew7.0% / -3.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Basic Materials
4-week rank- / 100
Group average2.8%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD52.0%positive activity pressure
RS63.0%positive relative leadership
Four-week leaders
IndustryIN Specialty Chemicals
4-week rank27 / 100
Group average5.8%
Trend breadth77.0%
Trend77.0%active weekly trend signals
MD75.0%positive activity pressure
RS72.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape52/100
Trend, activity pressure, participation, and risk combine to a 52/100 tape read.
Indicator analysis84/100Latest 12-week confirmation: trend 11/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.93; 2 reversal markers Next-Week ExpectancyNegative 39.94%Next-week expectancy is negative with a 39.94% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors36/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 2; Small Cap Core rank 74 SVQF33/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 1061.0 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment53/100Weighted news tone is neutral across 26 relevant articles.
Fineotex Chemicals Seeks Acquisitions Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 41.64 INR | 5.7% | 29.62 INR | 30.99 INR | 0.56 | 51.39 | 50.1M | On |
| 31 Jul 2026 | 39.40 INR | -0.5% | 29.00 INR | 30.91 INR | 0.62 | 46.18 | 56.5M | On |
| 24 Jul 2026 | 39.59 INR | 2.2% | 28.51 INR | 30.84 INR | 0.78 | 52.23 | 101.8M | On |
| 17 Jul 2026 | 38.75 INR | 4.8% | 28.03 INR | 30.78 INR | 0.91 | 47.05 | 60.8M | On |
| 10 Jul 2026 | 36.99 INR | -5.4% | 27.54 INR | 30.71 INR | 1.11 | 42.33 | 34.5M | On |
| 3 Jul 2026 | 39.12 INR | -4.4% | 27.12 INR | 30.64 INR | 1.28 | 51.37 | 7.8M | On |
| 26 Jun 2026 | 40.90 INR | -6.0% | 26.66 INR | 30.58 INR | 1.41 | 61.23 | 0 | On |
| 19 Jun 2026 | 43.52 INR | 11.1% | 26.14 INR | 30.50 INR | 1.59 | 73.80 | 9.2M | On |
| 12 Jun 2026 | 39.17 INR | -3.8% | 25.51 INR | 30.41 INR | 1.71 | 61.13 | 10.0M | On |
| 5 Jun 2026 | 40.73 INR | 1.9% | 25.06 INR | 30.35 INR | 1.71 | 71.26 | 15.3M | On |
| 29 May 2026 | 39.99 INR | 20.3% | 24.58 INR | 30.29 INR | 1.80 | 69.20 | 282.6M | On |
| 22 May 2026 | 33.24 INR | 30.7% | 24.24 INR | 30.23 INR | 1.53 | 41.63 | 500.1M | Off |
| 15 May 2026 | 25.44 INR | -9.6% | 23.99 INR | 30.21 INR | 1.23 | 9.72 | 35.1M | Off |
| 8 May 2026 | 28.15 INR | 22.5% | 23.96 INR | 30.21 INR | 1.08 | 18.78 | 70.1M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.